Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly’s connected insulin solutions
The Pharma Data
FEBRUARY 25, 2021
and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc’s software into Lilly’s connected insulin solutions, currently in development. Lilly will commercialize the pen platform, which will include the new app and Lilly’s connected insulin pen solutions.
Let's personalize your content